These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24944605)

  • 41. Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation.
    Leiss H; Niederreiter B; Bandur T; Schwarzecker B; Blüml S; Steiner G; Ulrich W; Smolen JS; Stummvoll GH
    Lupus; 2013 Jul; 22(8):778-92. PubMed ID: 23817510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Syk inhibitor attenuates inflammation in lupus mice from FcgRIIb deficiency but not in pristane induction: the influence of lupus pathogenesis on the therapeutic effect.
    Issara-Amphorn J; Somboonna N; Pisitkun P; Hirankarn N; Leelahavanichkul A
    Lupus; 2020 Sep; 29(10):1248-1262. PubMed ID: 32700597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes.
    Cardile V; Libra M; Caggia S; Frasca G; Umezawa K; Stivala F; Mazzarino MC; Bevelacqua Y; Coco M; Malaponte G
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):679-83. PubMed ID: 20337659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus.
    Calvani N; Satoh M; Croker BP; Reeves WH; Richards HB
    Kidney Int; 2003 Sep; 64(3):897-905. PubMed ID: 12911539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
    Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
    J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
    Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
    Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A nuclear factor-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates GVHD in allogeneic bone marrow transplantation.
    Yamanouchi S; Adachi Y; Shimo T; Umezawa K; Okigaki M; Tsuji S; Li M; Takaya J; Kuge T; Ikehara S; Kaneko K
    Immunobiology; 2015 Sep; 220(9):1059-66. PubMed ID: 26004346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
    Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
    Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dehydroxymethylepoxyquinomicin (DHMEQ) can suppress tumour necrosis factor-α production in lipopolysaccharide-injected mice, resulting in rescuing mice from death in vivo.
    Shimo T; Adachi Y; Umezawa K; Okigaki M; Takaya J; Taniuchi S; Ikehara S; Kaneko K
    Clin Exp Immunol; 2011 Nov; 166(2):299-306. PubMed ID: 21985376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.
    Richards HB; Satoh M; Shaw M; Libert C; Poli V; Reeves WH
    J Exp Med; 1998 Sep; 188(5):985-90. PubMed ID: 9730900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Experimental study of pristane-induced murine lupus model].
    Cui GM; Liu G; Liu W; Kan B; Mao YQ; Wei YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):309-12. PubMed ID: 16608103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A20 overexpression alleviates pristine-induced lupus nephritis by inhibiting the NF-κB and NLRP3 inflammasome activation in macrophages of mice.
    Li M; Shi X; Qian T; Li J; Tian Z; Ni B; Hao F
    Int J Clin Exp Med; 2015; 8(10):17430-40. PubMed ID: 26770333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    Martín-Márquez BT; Satoh M; Hernández-Pando R; Martínez-García EA; Petri MH; Sandoval-García F; Pizano-Martinez O; García-Iglesias T; Corona-Meraz FI; Vázquez-Del Mercado M
    PLoS One; 2021; 16(10):e0259114. PubMed ID: 34705865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
    Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
    Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
    Clynes R; Calvani N; Croker BP; Richards HB
    Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oleocanthal supplemented diet improves renal damage and endothelial dysfunction in pristane-induced systemic lupus erythematosus in mice.
    Montoya T; Sánchez-Hidalgo M; Castejón ML; Vazquéz-Román MV; de Sotomayor MA; Ortega-Vidal J; González ML; Alarcón-de-la-Lastra C
    Food Res Int; 2023 Jan; 163():112140. PubMed ID: 36596095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In Vivo Therapeutic Success of MicroRNA-155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage.
    Zhou S; Wang Y; Meng Y; Xiao C; Liu Z; Brohawn P; Higgs BW; Jallal B; Jia Q; Qu B; Huang X; Tang Y; Yao Y; Harley JB; Shen N
    Arthritis Rheumatol; 2016 Apr; 68(4):953-64. PubMed ID: 26556607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of DHMEQ, a novel nuclear factor-kappab inhibitor, on beta cell dysfunction in INS-1 cells.
    Saisho Y; Hirose H; Horimai C; Miyashita K; Takei I; Umezawa K; Itoh H
    Endocr J; 2008 May; 55(2):433-8. PubMed ID: 18385532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.